Because of their potent anti-inflammatory properties, corticosteroids have been used for
decades to treat many diseases, including rheumatic diseases. They are frequently used in …

There is convincing evidence for the known and unambiguously accepted beneficial effects
of glucocorticoids at low dosages. However, the implementation of existing …

Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …

Epidemiology is the study of the distribution and determinants of disease in human
populations. Over the past decade there has been considerable progress in our …

Objectives To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for vaccination in patients with autoimmune inflammatory rheumatic …

Objectives To update the evidence for the safety of synthetic disease-modifying
antirheumatic drugs (sDMARDs), glucocorticoids (GC) and biological DMARDs (bDMARDs) …

Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …

Anti-tumour necrosis factor (TNF) monoclonal antibodies or soluble TNF receptors have
become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid …

Evidence-based recommendations for vaccination of paediatric patients with rheumatic
diseases (PaedRD) were developed by following the EULAR standardised procedures for …

Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic
arthritis (PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of …